Drug Abuse

145 registered clinical trials studyying Drug Abuse — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Evaluation of Oral THC and CBD in Men and Women NCT05067387	University of California, Los Angeles	Phase 1
Not Yet Recruiting	Team-based Learning Intervention to Prevent Risk Factors for Chronic Diseases - a Cluster Randomized Trial NCT06894134	Professor Fernando Figueira Integral Medicine Institute	N/A
Not Yet Recruiting	HARM REDUCTION INTERVENTION FOR PEOPLE WHO USE ANABOLIC ANDROGENIC STEROIDS: THE RANDOMIZED CONTROLLED TRIAL NCT07039539	University of Sao Paulo	N/A
Completed	Personally-Tailored Opioid-overdose and Medication for Opioid Use Disorder (MOUD) Education (TOME) for Pregnan NCT06262347	T. John Winhusen, PhD	N/A
Active Not Recruiting	OUD Smartphone Services NCT06134882	Western Michigan University	N/A
Completed	An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African Community NCT06428162	Deraya University	—
Completed	Satir Model for Self-esteem, Mental Health, and Family Function Among Individuals With Substance Use Disorders NCT06044363	Hong Kong Metropolitan University	N/A
Recruiting	Peer-led Personalized Support Program NCT05918601	Chinese University of Hong Kong	N/A
Recruiting	Wakaya: Rising Up for Choctaw Youth Health NCT05818384	University of Washington	N/A
Recruiting	AA on Drug Abusers by Nursing Students NCT05877742	The Hong Kong Polytechnic University	N/A
Completed	An Explorative Pilot Study of a New Mobile Phone Application Measuring Eye Parameters of Eyes in Patients With NCT05737550	Kontigo Care AB	N/A
Completed	A First Study in Healthy Volunteers of a New Mobile Phone Application Measuring the Eyes Before and After Medi NCT05731999	Kontigo Care AB	N/A
Unknown	Effect of Folic Acid on the Presentation of Nuclear Abnormalities in People With a History Drug Abuse NCT05712044	Centro Universitario de Tonalá	N/A
Completed	Evaluation of Smoked THC and CBD in Men and Women NCT05037487	University of California, Los Angeles	Phase 1
Unknown	ASSIST: A Surveillance Study of Illicit Substance Toxicity NCT05329142	NHS Greater Glasgow and Clyde	—
Not Yet Recruiting	Neurobiological Effects of Transcranial Direct Current Stimulation Treatment in Alcohol Use Disorder NCT04897295	ITAB - Institute for Advanced Biomedical Technologies	N/A
Completed	Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-stud NCT03911739	T. John Winhusen, PhD	—
Unknown	Addiction in Intensive Cardiac Care Units NCT05063097	Assistance Publique - Hôpitaux de Paris	—
Unknown	Peer-delivered Brief Motivational Interviewing Via Instant Messaging Interaction in Reducing the Drug Abuse Am NCT04672746	The University of Hong Kong	N/A
Active Not Recruiting	Factors Predicting Outcome in Group Treatment of Alcohol Use Disorders (AUDs) NCT04822987	The Hospital of Vestfold	—
Completed	Delivering Contingency Management in Outpatient Addiction Treatment NCT04544124	University of Calgary	N/A
Completed	Peer-delivered Follow-up Text Communication After a Brief Motivational Interviewing (MI) for Adolescent Drug A NCT04634968	The University of Hong Kong	N/A
Unknown	Hotline Service for Drug-abusing Youth and Young Adults NCT04461314	The University of Hong Kong	N/A
Completed	Medication Treatment for Opioid Use Disorder in Expectant Mothers NCT03918850	T. John Winhusen, PhD	Phase 3
Completed	Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study NCT03911466	T. John Winhusen, PhD	—
Completed	Hospitalisations of Teenagers and Young Adulthoods in Mayotte After Consumption of an Illegal Drug Called " Ch NCT04547751	University Hospital, Bordeaux	—
Completed	Isolated During COVID-19: Effects of COVID-19's Social Restrictions on Loneliness and Psychosocial Symptomatol NCT04440098	University of Miami	—
Completed	Nitrous Oxyde Misuse Among Teenagers Consulting in an Addictology Center Dedicated to Young Drug Users in Mont NCT04301024	University Hospital, Montpellier	—
Recruiting	Structured Physical Exercise in Short-term Inpatient Treatment of Substance Use Disorder NCT04141202	St. Olavs Hospital	—
Completed	Westlake Personalized Nutrition and Health Cohort for Drug Addicts NCT04105621	Westlake University	—
Withdrawn	A Community-University Approach to Preventing HIV NCT03938077	University of Michigan	N/A
Completed	A Family-based Intervention for Drug-abusing Adults in Hong Kong NCT04725266	The University of Hong Kong	N/A
Unknown	Population Screening Using Smartphone in Milpa Alta NCT04067063	Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz	—
Unknown	Massive Mental Health Screening Using Smartphones in 24 Pre-graduate Education Centers in Mexico City: TEDUCA NCT04067076	Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz	—
Completed	Leveraging Implementation Science to Increase Access to Trauma Treatment for Incarcerated Drug Users NCT04007666	University of Arkansas	N/A
Completed	Ketamine IV Classic Protocol : Five Years Follow up NCT04824157	Sheba Medical Center	—
Unknown	Motivational Strategies in Batterer Intervention Programs for Offenders With Alcohol/Drug Abuse Problems (IMP- NCT03885349	University of Valencia	N/A
Completed	CBT4CBT for Women in Residential Treatment for Substance Use Disorders NCT03678051	Virginia Commonwealth University	N/A
Completed	Drug Abuse Among Elective Surgeries: an Observational Study. NCT05123521	Cairo University	—
Completed	Naloxone Nasal Spray Compared With Naloxone Injection for Opioid Overdoses Outside the Hospital NCT03518021	Norwegian University of Science and Technology	Phase 3
Completed	Preventing HIV/STI in Urban Adolescents Via an mHealth Primary Care Intervention NCT03368456	University of Michigan	N/A
Completed	Arsha Vidya Program for Preventing Drug Abuse Among Disadvantaged Children in Urban Slums NCT03472222	NMP Medical Research Institute	N/A
Completed	A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Op NCT02751762	Member Companies of the Opioid PMR Consortium	—
Completed	Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users NCT03152123	Bioprojet	Phase 1
Unknown	Double Blind Placebo Control Opipramol-Baclofen Treatment for Addiction NCT03065998	Ministry of Health, Israel	EARLY_Phase 1
Completed	A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid Overdoses NCT02922959	University of Cincinnati	N/A
Unknown	90-Day Online Substance Use Program NCT03069118	Workit Health	N/A
Terminated	Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic NCT02741076	Member Companies of the Opioid PMR Consortium	Phase 4
Completed	Testing a Multilevel Preventive Intervention in Youth Courts NCT02764099	National Health Promotion Associates, Inc.	N/A
Completed	Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketam NCT02682225	Janssen Research & Development, LLC	Phase 1
Completed	A Study to Evaluate Abuse Potential of Istradefylline NCT02609477	Kyowa Kirin Co., Ltd.	Phase 1
Recruiting	Suicidal Behavior in Patients Diagnosed With Bipolar Disorder NCT02604277	Emory University	N/A
Completed	Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication NCT02660619	Member Companies of the Opioid PMR Consortium	—
Completed	Enhancing Housing First Programs With a Social Network Substance Use Intervention NCT02140359	RAND	N/A
Completed	An Observational Study to Develop Algorithms for Identifying Opioid Abuse and Addiction Based on Admin Claims NCT02667262	Member Companies of the Opioid PMR Consortium	—
Completed	Study to Validate Coded Medical Terms Used to Identify Opioid-Related Overdose in Databases Used for PMR Study NCT02667197	Member Companies of the Opioid PMR Consortium	—
Completed	A Quantitative Study to Assess the Construct Validity of the Prescription Opioid Misuse and Abuse Questionnair NCT02678507	Member Companies of the Opioid PMR Consortium	—
Completed	Cross-Sectional Study to Define and Validate "Doctor/Pharmacy Shopping" as Outcomes Suggestive of Abuse and/or NCT02668549	Member Companies of the Opioid PMR Consortium	—
Completed	A Qualitative Study to Assess the Content Validity of the Prescription Opioid Misuse and Abuse Questionnaire NCT02660606	Member Companies of the Opioid PMR Consortium	—
Completed	Implementing Screening for Cannabis and Other Drug Use Disorders in Primary Care: Impact on Diagnosis and Trea NCT06249542	Kaiser Permanente	N/A
Completed	A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or NCT02667158	Member Companies of the Opioid PMR Consortium	—
Completed	Study to Eval Relation Btw Doctor/Pharmacy Shopping & Outcomes of Misuse, Diversion, Abuse, Addiction by Med R NCT02667210	Member Companies of the Opioid PMR Consortium	—
Completed	Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks NCT02224508	Kaiser Permanente	—
Completed	Phone Interview to Prevent Recurring Opioid Overdoses NCT02282306	University of Cincinnati	N/A
Completed	A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse NCT02476877	Advanced Clinical Laboratory Solutions, Inc.	—
Withdrawn	Trial of Computerized MET for Adolescent Substance Use NCT01784653	Boston Children's Hospital	Phase 1
Completed	Computerized Brief Intervention vs. Delayed Computerized Brief Intervention NCT01936623	Friends Research Institute, Inc.	N/A
Withdrawn	Reducing Problematic Substance Use in Youth With Chronic Medical Conditions NCT01709201	Boston Children's Hospital	N/A
Completed	A Web App for Patients With Alcohol and Drug Use Problems in Primary Care NCT01830114	Behavior Therapy Associates, LLP	N/A
Withdrawn	The Therapeutic Workplace Intervention in Community Settings NCT01841892	University of Maryland, Baltimore County	N/A
Completed	Brief Intervention for Rural Women at High Risk for HIV/HCV NCT01840722	Michele Staton	N/A
Completed	Preventing Drug Abuse Among Hispanic Adolescents NCT02375516	Columbia University	N/A
Completed	Multi-court Trial of NBP to Prevent Substance Abuse and Mental Health Disorders (MTC) NCT06132971	Arizona State University	N/A
Completed	Indirect Assessment and Intervention for Perinatal Drug Use NCT01650675	Wayne State University	Phase 2
Completed	A Study to Assess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid Users NCT01596673	Cephalon	Phase 1
Unknown	Prevention and Reduction of Alcohol and Drug Problems in a Clinical Psychiatric Youth Population NCT01595568	St. Justine's Hospital	N/A
Withdrawn	Study in Healthy Recreational Polydrug Users to Measure the Abuse Potential of TC-5214 NCT01500018	AstraZeneca	Phase 1
Completed	Development and Testing of Adolescent Twelve-Step Facilitation NCT01449981	Massachusetts General Hospital	N/A
Completed	Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth NCT01442753	University of Minnesota	N/A
Withdrawn	cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use NCT01275391	Boston Children's Hospital	Phase 1 / Phase 2
Completed	Impact of Online Patient Feedback (OQ) to Therapist NCT01891045	Oslo University Hospital	N/A
Completed	Multimedia Toolkits to Implement 12-Step Recovery Concepts in Group Counseling NCT02333357	Treatment Research Institute	N/A
Completed	Healthier You: Optimizing Screening, Brief Interventions, and Referral to Treatment (SBIRT) in the Emergency D NCT01113190	University of Michigan	N/A
Completed	Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments NCT01207791	University of New Mexico	N/A
Completed	Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use NCT00907309	Boston Children's Hospital	Phase 1 / Phase 2
Completed	Screening Brief Intervention Referral to Treatment (SBIRT) in New Mexico NCT01131520	Friends Research Institute, Inc.	N/A
Completed	Dynamic Assessment and Referral System - Evaluation NCT01153373	University of Massachusetts, Worcester	Phase 2
Completed	The Effects of Expectation on Natural and Drug -Induced Rewards NCT01036230	National Institute on Drug Abuse (NIDA)	—
Completed	Screening, Brief Intervention, and Referral to Treatment for Drug Use NCT01683227	San Diego State University	N/A
Completed	Oral Fluid, Plasma and Whole Pharmacokinetics and Stability Following Smoked Cannabis NCT01071616	National Institute on Drug Abuse (NIDA)	Phase 1
Completed	Multidisciplinary Approach to Reduce Injury and Substance Abuse NCT01048359	University of Texas at Austin	Phase 3
Withdrawn	Multiple Behavior Screening, Brief Intervention and Referral to Treatment (SBIRT) Model of Drug Abuse in Prima NCT01439334	University of Florida	N/A
Completed	Prenatal Drug Exposure: Effects on the Adolescent Brain and Behavior Development NCT01020669	National Institute on Drug Abuse (NIDA)	—
Terminated	Brain Glutamate Receptors and Cocaine Dependence NCT00951314	National Institute on Drug Abuse (NIDA)	—
Completed	Developing Field Tools for Real-Time Assessment of Exposure to Psychosocial Stress and Drug Use in an Outpatie NCT00787423	National Institute on Drug Abuse (NIDA)	—
Completed	Behavioral Couples Therapy for Female Drug-Abusing Patients NCT01189305	Harvard University	Phase 2
Completed	Prevention of Post Sexual Assault Stress NCT01430624	Medical University of South Carolina	Phase 1 / Phase 2
Completed	Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use NCT00876941	Boston Medical Center	Phase 3
Completed	Abuse Potential of Single Doses of Lorcaserin in Healthy Recreational Polydrug Users NCT00828659	Eisai Inc.	Phase 1
Completed	Effects of Levetiracetam (Keppra) on Alcohol Consumption NCT01168687	University of California, San Francisco	N/A
Completed	Disulfiram Interactions With HIV Medications: Clinical Implications NCT00878306	University of California, San Francisco	Phase 1
Completed	Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment NCT02228044	George Mason University	N/A
Completed	Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P0 NCT00725608	Indivior Inc.	—
Completed	Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill NCT00809770	University of Washington	N/A
Completed	Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Stu NCT00723749	Indivior Inc.	—
Completed	Quetiapine for the Reduction of Cocaine Use NCT00631748	Seattle Institute for Biomedical and Clinical Research	N/A
Completed	Pharmacological, Clinical and Statistical Assessment of a New Tool Available for Pharmacodependence Report Eva NCT01052675	Nantes University Hospital	—
Completed	Stimulant Abuser Groups to Engage in 12-Step NCT00573183	University of Washington	Phase 3
Withdrawn	Brief Integrative Alcohol Interventions for Adolescents NCT01427465	University of Florida	N/A
Completed	Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients NCT00684073	Indivior Inc.	Phase 4
Completed	Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in NCT00723697	Indivior Inc.	—
Completed	Adventure: Teacher Delivered Personality-targeted Interventions for Substance Misuse NCT00776685	King's College London	Phase 2 / Phase 3
Completed	Clinical Studies on the Therapeutic Effects of Mirtazapine on Drug-craving in Cocaine Addicts. NCT01949571	Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente	Phase 2
Completed	Fetal Neurobehavior in Non-methadone Maintained Women in Substance Abuse Treatment NCT00522626	Johns Hopkins University	—
Completed	Prometa Pharmacotherapy for Methamphetamine Dependence NCT00260481	University of California, Los Angeles	Phase 2 / Phase 3
Completed	Project Health Link: Connecting Patients With Services NCT00251173	University of Michigan	N/A
Completed	Effect of Functional Genetic Polymorphisms on Brain Morphology and Function NCT01035723	National Institute on Drug Abuse (NIDA)	—
Completed	Brief Intervention for Drug Abusing Adolescents NCT00350909	University of Minnesota	Phase 2
Completed	Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM) NCT00798538	Yale University	Phase 4
Completed	Cognitive Task Development and Implementation for Functional MRI Studies NCT01036685	National Institute on Drug Abuse (NIDA)	—
Completed	Adolescent Family-Based Alcohol Prevention NCT00858065	Pacific Institute for Research and Evaluation	N/A
Completed	Reward Processing in Cocaine Addiction NCT01036074	National Institute on Drug Abuse (NIDA)	—
Completed	Youth Drug Abuse Family and Cognitive-Behavioral Therapy NCT00198874	University of Florida	Phase 2
Completed	Brief Youth Substance Use Intervention for Primary Care NCT00292240	RAND	N/A
Terminated	Behavioral Therapy Development for Methamphetamine Abuse NCT00252434	University of California, Los Angeles	Phase 1
Completed	Prevention Program for Problem Behaviors in Girls in Foster Care NCT00239837	Oregon Social Learning Center	N/A
Completed	Personality-targeted Interventions for Adolescent Alcohol Misuse NCT00344474	King's College London	Phase 2 / Phase 3
Recruiting	Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging NCT01036581	National Institute on Drug Abuse (NIDA)	N/A
Completed	Improving Hepatitis C Treatment in Injection Drug Users NCT00148031	State University of New York - Upstate Medical University	Phase 4
Completed	Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse NCT00671632	Takeda	Phase 2
Completed	Effects of Nicotine on Cognitive Task Performance and Brain Activity as Measured by fMRI NCT01036711	National Institute on Drug Abuse (NIDA)	—
Completed	Self-Selected Brief Alcohol Intervention for Adolescents NCT00383838	RAND	N/A
Completed	Effects of Nicotine on Brain Activity as Measured by fMRI NCT01037153	National Institute on Drug Abuse (NIDA)	—
Completed	Reinforcement-Based Treatment and Abstinence-Contingent Housing for Drug Abusers NCT00685620	National Institute on Drug Abuse (NIDA)	Phase 4
Completed	Neurobehavioral Model of HIV in Injection Drug Users NCT00198861	The City College of New York	—
Completed	Cognitive Behavioral Stress Management for HIV+ Drug Abusers NCT00722644	National Institute on Drug Abuse (NIDA)	Phase 1
Completed	Student Athlete Testing Using Random Notification NCT00451854	National Institute on Drug Abuse (NIDA)	N/A
Completed	PET Assays of Striatal Dopamine Marker in Cocaine Craving NCT01036516	National Institute on Drug Abuse (NIDA)	—
Completed	Acute Intervention to Reduce Distress Following Sexual Assault NCT01622855	Medical University of South Carolina	Phase 1 / Phase 2
Unknown	ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner Databases NCT02897414	ER/LA Opioid REMS Program Companies (RPC)	—
Unknown	Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid Analgesics NCT02920775	ER/LA Opioid REMS Program Companies (RPC)	—
Unknown	Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers NCT02871232	ER/LA Opioid REMS Program Companies (RPC)	—
Unknown	Evaluation of Changes in Prescribing Behavior of ER/LA Opioid Prescribers NCT02920762	ER/LA Opioid REMS Program Companies (RPC)	—
Unknown	Evaluation of Drug Utilization Patterns for Extended Release/Long Acting Opioids and Comparator Products NCT02925806	ER/LA Opioid REMS Program Companies (RPC)	—
Unknown	ER/LA Opioid Surveillance for Emergency Department Visits and Hospitalizations for Overdose and Poisoning NCT02866266	ER/LA Opioid REMS Program Companies (RPC)	—